Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#ILCA2024

Home » #ILCA2024
ILCA Chair Interview | Dr. Tim Meyer: Focusing on Advances in Liver Cancer Treatment and Shaping Future Progress

ILCA Chair Interview | Dr. Tim Meyer: Focusing on Advances in Liver Cancer Treatment and Shaping Future Progress

Posted by By Lisa Cui 2024.11.06
From October 17 to 19, 2024, in the season of golden autumn, the 18th International Liver Cancer Association (ILCA) Annual Conference was successfully held. This grand event attracted numerous top…
Read More
ILCA 2024 Reveals: Sorafenib-Toripalimab and Anlotinib-Sintilimab Combos Yield Unprecedented Results in Liver Cancer

ILCA 2024 Reveals: Sorafenib-Toripalimab and Anlotinib-Sintilimab Combos Yield Unprecedented Results in Liver Cancer

Posted by By Mourabit Halima 2024.10.25
Editor’s Note: From October 17-19, 2024, global experts and scholars in liver cancer research gathered in Toronto, Canada, to witness the 18th International Liver Cancer Association (ILCA) Annual Conference. At…
Read More
Recent Posts
  • CURC & ARUF | Professor Linhui Wang: Addressing Complications in Retroperitoneal Surgery and Looking Ahead to the Future of Domestic Surgical Robots
  • CUDA Yanqi Lake Conference | Professor Ninghan Feng: Multidisciplinary Integration Empowering the Management of Complex Urologic Tumors — The Practice and Future of the MDT Model
  • CUDA Yanqi Lake Conference | Exclusive Interview with Professor Hong Liao: In the Era of Precision Therapy for Prostate Cancer, How Do We Move from “Experience-Driven” to “Evidence-Driven” Care?
  • CUDA Yanqi Lake Conference | From Personal Mastery to Broader Impact: The Growth and Legacy of a Urologic Surgeon
  • AOT 2026 | Professor Matthias Stelljes: Therapeutic Pathways and Key Decision-Making Considerations in Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
Recent Comments
    Archives
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top